Gastrointestinal tract involvement of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after cord blood transplantation

Hiromi Wakamatsu; Koshi Akahane; Shin Kasai; Atsushi Watanabe; Kumiko Goi

doi:10.1111/ped.15233

Gastrointestinal tract involvement of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after cord blood transplantation

Pediatr Int. 2022 Jan;64(1):e15233. doi: 10.1111/ped.15233.

Authors

Hiromi Wakamatsu^{1

2}, Koshi Akahane¹, Shin Kasai¹, Atsushi Watanabe¹, Kumiko Goi¹

Affiliations

¹ Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
² Department of Pediatrics, Kofu-Kyoritsu Hospital, Kofu, Yamanashi, Japan.

PMID: 35831256
DOI: 10.1111/ped.15233

No abstract available

Keywords: Epstein-Barr virus-associated post-transplant lymphoproliferative disorder; gastrointestinal tract; neuroblastoma; rituximab; unrelated cord blood transplantation.

MeSH terms

Cord Blood Stem Cell Transplantation* / adverse effects
Epstein-Barr Virus Infections* / diagnosis
Epstein-Barr Virus Infections* / etiology
Gastrointestinal Tract
Hematopoietic Stem Cell Transplantation*
Herpesvirus 4, Human
Humans
Lymphoproliferative Disorders* / diagnosis
Lymphoproliferative Disorders* / etiology
Rituximab

Substances

Rituximab